Christopher Thomas Giordano
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
—
Avg. 90-day return+62.2%
vs. S&P 500+56.7%
Beat the market100%
Paper profit on buys−$15K
Total bought / sold$40K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 15SEC | TENXTenax Therapeutics, Inc. | Buy | 6,00017,324 held (+53%) | $1.88 | $11K | -0.5% |
| Sep 15SEC | TENXTenax Therapeutics, Inc. | Buy | 4,85022,174 held (+28%) | $1.82 | $9K | +2.7% |
| Nov 20SEC | TENXTenax Therapeutics, Inc. | Buy | 1,612new position | $7.75 | $12K | -75.9% |
| Nov 20SEC | TENXTenax Therapeutics, Inc. | Buy | 4552,067 held (+28%) | $7.51 | $3K | -75.1% |
| Nov 20SEC | TENXTenax Therapeutics, Inc. | Buy | 5382,605 held (+26%) | $7.59 | $4K | -75.4% |
- Buy
CEO Christopher Thomas Giordano bought $11K of TENX at $1.88 — raises the stake by 53%.
- Buy
CEO Christopher Thomas Giordano bought $9K of TENX at $1.82 — raises the stake by 28%.
- Buy
CEO Christopher Thomas Giordano bought $12K of TENX at $7.75 — first open-market purchase in our records; opens a new position.
- Buy
CEO Christopher Thomas Giordano bought $3K of TENX at $7.51 — raises the stake by 28%.
- Buy
CEO Christopher Thomas Giordano bought $4K of TENX at $7.59 — raises the stake by 26%.